NUCLEOLIN and breast cancer: As a tumor suppressor, tRF3E causes the release of p53 mRNA and further promotes p53 translation through competitive interactions with nucleolin (NCL), an RNA-binding protein overexpressed in BC, resulting in inhibition of cancer cell proliferation [64].